Differential regulation by stimulants of neocortical expression of mrt1, arc, and homer1a mRNA in the rats treated with repeated methamphetamine

Synapse

Volumn 49, Issue 3, 2003, Pages 143-149

  Fujiyama, Ko ^a,b   Kajii, Yasushi ^a,c,d   Hiraoka, Shuichi ^a,e   Nishikawa, Toru ^a,c  

^a NATIONAL INSTITUTE OF NEUROSCIENCE   (Japan)

^b TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^d MITSUBISHI TANABE PHARMA CORPORATION   (Japan)

^e Pharmaceutical Research Center   (Japan)

Author keywords

Behavioral sensitization; Challenge dose; Cocaine; Methamphetamine; Repeated treatment

Indexed keywords

CENTRAL STIMULANT AGENT; COCAINE; MESSENGER RNA; METHAMPHETAMINE; PDZ PX PROTEIN; PROTEIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARC GENE; ARTICLE; BEHAVIOR; CONTROLLED STUDY; DRUG REEXPOSURE; DRUG WITHDRAWAL; GENE; GENE EXPRESSION REGULATION; HOMER1A GENE; MALE; MRT1 GENE; NEOCORTEX; NERVE CELL PLASTICITY; NONHUMAN; PRIORITY JOURNAL; PROVOCATION TEST; RAT; SENSITIZATION; SIGNAL TRANSDUCTION;

ANIMALS; BEHAVIOR, ADDICTIVE; BEHAVIOR, ANIMAL; CARRIER PROTEINS; CENTRAL NERVOUS SYSTEM STIMULANTS; COCAINE; CYTOSKELETAL PROTEINS; GENE EXPRESSION REGULATION; MALE; METHAMPHETAMINE; NEOCORTEX; NERVE TISSUE PROTEINS; NEUROPEPTIDES; QUINOLINES; RATS; RATS, WISTAR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; UP-REGULATION;

EID: 0037826928     PISSN: 08874476     EISSN: None     Source Type: Journal    
DOI: 10.1002/syn.10220     Document Type: Article

References (35)

1. Becker-Andre M, Hahlbrock K. 1989. Absolute mRNA quantification using the polymerase chain reaction (PCR). A novel approach by a PCR aided transcript titration assay (PATTY). Nucleic Acids Res 17:9437-9446.
2. Berke JD, Hyman SE. 2000. Addiction, dopamine, and the molecular mechanisms of memory. Neuron 25:515-532.
3. Bibb JA, Chen J, Taylor JR, Svenningsson P, Nishi A, Snyder GL, Yan Z, Sagawa ZK, Ouimet CC, Nairn AC, Nestler EJ, Greengard P. 2001. Effects of chronic exposure to cocaine are regulated by the neuronal protein Cdk5. Nature 410:376-380.
4. Bjijou Y, De Deurwaerdere P, Spampinato U, Stinus L, Cador M. 2002. D-amphetamine-induced behavioral sensitization: effect of lesioning dopaminergic terminals in the medial prefrontal cortex, the amygdala and the entorhinal cortex. Neuroscience 109:499-516.
5. Brakeman PR, Lanahan AA, O'Brien R, Roche K, Barnes CA, Huganir RL, Worley PF. 1997. Homer: a protein that selectively binds metabotropic glutamate receptors. Nature 386:284-288.
6. Cha XY, Pierce RC, Kalivas PW, Mackler SA. 1997. NAC-1, a rat brain mRNA, is increased in the nucleus accumbens three weeks after chronic cocaine self-administration. J Neurosci 15:6864-6871.
7. Cochran SM, Fujimura M, Morris BJ, Pratt JA. 2002. Acute and delayed effects of phencyclidine upon mRNA levels of markers of glutamatergic and GABAergic neurotransmitter function in the rat brain. Synapse 46:206-214.
8. Fanning AS, Anderson JM. 1999. Protein modules as organizers of membrane structure. Curr Opin Cell Biol 11:432-439.
9. Feldpausch DL, Needham LM, Stone MP, Althaus JS, Yamamoto BK, Svensson KA, Merchant KM. 1998. The role of dopamine D4 receptor in the induction of behavioral sensitization to amphetamine and accompanying biochemical and molecular adaptations. J Pharmacol Exp Ther 286:497-508.
10. Flores C, Samaha AN, Stewart J. 2000. Requirement of endogenous basic fibroblast growth factor for sensitization to amphetamine. J Neurosci 20:RC55.
11. Freeman WM, Brebner K, Lynch WJ, Patel KM, Robertson DJ, Roberts DC, Vrana KE. 2002. Changes in rat frontal cortex gene expression following chronic cocaine. Brain Res Mol Brain Res 104:11-20.
12. Fujiwara Y, Kazahaya M, Nakashima M, Ootsuki S. 1987. Behavioral sensitization to methamphetamine in the rat: an ontogenic study. Psychopharmacology 91:316-319.
13. Hashimoto T, Kajii Y, Nishikawa T. 1998. Psychotomimetics-induction of tissue plasminogen activator mRNA in corticostriatal neurons in rat brain. Eur J Neurosci 10:3387-3399.
14. Higuchi R, Krummel B, Saiki RK. 1988. A general method of in vitro preparation and specific mutagenesis of DNA fragments: study of protein and DNA interactions. Nucleic Acids Res 16:7351-7367.
15. Hiroaki H, Ito T, Sumimoto H, Kohada D. 2001. Solution structure of the PX domain, a target of the SH3 domain. Nat Struct Biol 8:526-530.
16. Kajii Y, Muraoka S, Hiraoka S, Fujiyama K, Umino A, Nishikawa T. 2003. A developmentally regulated and psychostimulant-inducible novel rat gene mrt1 encoding PDZ-PX proteins isolated in the neocortex. Mol Psychiatry (in press).
17. Kalivas PW, Stewart J. 1991 Dopamine transmission in the initiation and expression of drug- and stress-induced sensitization of motor activity. Brain Res Brain Res Rev 16:223-244.
18. Kalivas PW, Duffy P, Mackler SA. 1999. Interrupted expression of NAC-1 augments the behavioral responses to cocaine. Synapse 33:153-159.
19. Kodama M, Akiyama K, Ujike H, Shimizu Y, Tanaka Y, Kuroda S. 1998. A robust increase in expression of arc gene, an effector immediate early gene, in rat brain after acute and chronic methamphetamine administration. Brain Res 796:273-283.
20. Kolta MG, Scalzo FM, Ali SF, Holson RR. 1990. Ontogeny of the enhanced behavioral response to amphetamine in amphetamine-pretreated rats. Psychopharmacology 100:377-382.
21. Mackler SA, Korutla L, Cha XY, Koebbe MJ, Fournier KM, Bowers MS, Kalivas PW. 2000. NAC-1 is a brain POZ/BTB protein that can prevent cocaine-induced sensitization in the rat. J Neurosci 20:6210-6217.
22. Martin KC. 2001. Arc mRNA dynamics: return to sender - the NMDA receptor provides the targeting address for Arc mRNA. Trends Neurosci 24:621-623.
23. Messaoudi E, Ying SW, Kanhema T, Croll SD, Bramham CR. 2002. Brain-derived neurotrophic factor triggers transcription-dependent, late phase long-term potentiation in vivo. J Neurosci 22:7453-7461.
24. Nestler EJ. 2001. Molecular basis of long-term plasticity underlying addiction. Nat Rev Neurosci 2:119-128.
25. Nishikawa T, Mataga N, Takashima M, Toru M. 1983. Behavioral sensitization and relative hyperresponsiveness of striatal and limbic dopaminergic neurons after repeated methamphetamine treatment. Eur J Pharmacol 88:195-204.
26. Nishikawa T, Umino A, Kashiwa A, Ooshima A, Nomura N, Takahashi K. 1993. Stimulant-induced behavioral sensitization and cerebral neurotransmission. In: Toru M, editor. Neurotransmitters in neuronal plasticity and psychiatric disorders. Tokyo: Excerpta Medica. p 53-62.
27. Robinson TE, Becker JB. 1986. Enduring changes in brain and behavior produced by chronic amphetamine administration: a review and evaluation of animal models of amphetamine psychosis. Brain Res Rev 396:157-198.
28. Robinson TE, Berridge KC. 1993. The neural basis of drug craving: an incentive-sensitization theory of addiction. Brain Res Brain Res Rev 18:247-291.
29. Sato M, Numachi Y, Hamamura T. 1992. Relapse of paranoid psychotic state in methamphetamine model of schizophrenia. Schizophr Bull 18:115-122.
30. Swanson CJ, Baker DA, Carson D, Worley PF, Kalivas PW. 2001. Repeated cocaine administration attenuates group I metabotropic glutamate receptor-mediated glutamate release and behavioral activation: a potential role for Homer. J Neurosci 21:9043-9052.
31. Thomas U. 2002. Modulation of synaptic signalling complexes by Homer proteins. J Neurochem 81:407-413.
32. Turgeon SM, Pollack AE, Fink JS. 1997. Enhanced CREB phosphorylation and changes in c-Fos and FRA expression in striatum accompany amphetamine sensitization. Brain Res 749:120-126.
33. Utena H. 1996. Behavioral aberrations in methamphetamine-intoxicated animals and chemical correlates in the brain. Prog Brain Res 21:192-207.
34. Vanderschuren LJ, Kalivas PW. 2000. Alterations in dopaminergic and glutamatergic transmission in the induction and expression of behavioral sensitization: a critical review of preclinical studies. Psychopharmacology (Berl) 151:99-120.
35. Wang XB, Funada M, Imai Y, Revay RS, Ujike H, Vandenbergh DJ, Uhl GR. 1997. rGβ1: a psychostimulant-regulated gene essential for establishing cocaine sensitization. J Neurosci 17:5993-6000.